Xanax and Cancer Lawsuits in New York

Emerging research has raised concerns about a possible link between long-term benzodiazepine use, including Xanax (alprazolam), and increased cancer risk. While litigation is developing, plaintiffs typically allege that manufacturers failed to adequately warn patients and prescribers about potential long-term risks. If you were diagnosed with cancer after prolonged Xanax use, you may have grounds for a product liability claim in New York.

Under CPLR §214, New York’s general personal injury statute of limitations is three years from the date of injury or diagnosis. However, the discovery rule may apply if you could not reasonably have known the connection between Xanax and your cancer diagnosis earlier. Consult a New York attorney immediately to preserve your right to sue — delays can permanently bar your claim.

Potential defendants may include the pharmaceutical manufacturer, generic drug makers, and in some cases distributors or prescribers, depending on the facts of your case. Product liability claims in New York can proceed under theories of failure to warn, design defect, or manufacturing defect. An attorney can evaluate which parties may bear responsibility given your specific circumstances.

Document everything — your prescription history, dosage, duration of use, and your cancer diagnosis and treatment records. Do not stop taking any medication without consulting your doctor. Then contact a New York personal injury attorney as soon as possible to evaluate your claim before the statute of limitations expires under CPLR §214.